AI English summary of an SEC filing — figures as filed
Cardinal Health said on August 27, 2025 it completed a public offering of $600,000,000 aggregate principal amount of 4.500% Notes due 2030 and $400,000,000 aggregate principal amount of 5.150% Notes due 2035.
Key points
AI summaryCardinal Health said on August 27, 2025 it completed a public offering of $600,000,000 aggregate principal amount of 4.500% Notes due 2030 and $400,000,000 aggregate principal amount of 5.150% Notes due 2035.
The company said it intends to use the net proceeds from the sale of the Notes to fund a portion of the consideration payable in connection with its proposed acquisition of Solaris Health and the fees and expenses in connection therewith. It added that pending application of the proceeds to fund the consideration payable in connection with the acquisition, the company may temporarily use such funds for general corporate purposes.
Cardinal Health said if the acquisition is not consummated on or before the later of August 12, 2026 (the End Date) and the date that is 5 business days after any later date to which the End Date may be extended, or if the company notifies the Trustee that it will not pursue the consummation of the acquisition, the company will be required to redeem the Notes in whole at a special mandatory redemption price equal to 101% of the aggregate principal amount of the Notes being redeemed, plus accrued and unpaid interest.
The company said the proceeds from the sale of the Notes will not be deposited into an escrow account pending completion of the acquisition or any special mandatory redemption, nor will the company be required to grant any security interest or other lien on those proceeds to secure any redemption of the Notes.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
$600,000,000 4.500% Notes due 2030 and $400,000,000 5.150% Notes due 2035 offering completed
Cardinal Health said on August 27, 2025 it completed a public offering of $600,000,000 aggregate principal amount of 4.500% Notes due 2030 and $400,000,000 aggregate principal amount of 5.150% Notes due 2035.
Source · Based on the filing body and exhibits
Net proceeds from Notes sale to fund portion of Solaris Health acquisition consideration
The company said it intends to use the net proceeds from the sale of the Notes to fund a portion of the consideration payable in connection with its proposed acquisition of Solaris Health and the fees and expenses in connection therewith. It added that pending application of the proceeds to fund the consideration payable in connection with the acquisition, the company may temporarily use such funds for general corporate purposes.
Source · Based on the filing body and exhibits
Special mandatory redemption required if acquisition not completed by End Date
Cardinal Health said if the acquisition is not consummated on or before the later of August 12, 2026 (the End Date) and the date that is 5 business days after any later date to which the End Date may be extended, or if the company notifies the Trustee that it will not pursue the consummation of the acquisition, the company will be required to redeem the Notes in whole at a special mandatory redemption price equal to 101% of the aggregate principal amount of the Notes being redeemed, plus accrued and unpaid interest.
Source · Based on the filing body and exhibits
Proceeds from Notes sale not subject to escrow deposit or security interest
The company said the proceeds from the sale of the Notes will not be deposited into an escrow account pending completion of the acquisition or any special mandatory redemption, nor will the company be required to grant any security interest or other lien on those proceeds to secure any redemption of the Notes.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…